← Open Payments lookup

CAITLIN BATMAN: Open Payments

NPI 1396078150 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,575 in 123 payments from 12 companies in 2025. Trend: 2023 $790 · 2024 $1,608 · 2025 $2,575

Food & beverage: $2,575
CompanyPaymentsAmount
ABBVIE INC.49$612
Teva Pharmaceuticals USA, Inc.15$473
Alkermes, Inc.31$470
E.R. Squibb & Sons, L.L.C.9$373
Neurocrine BioSciences, Inc.3$179
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$178
Indivior Inc.2$164
Vanda Pharmaceuticals Inc.2$38
Supernus Pharmaceuticals, Inc.2$33
Otsuka America Pharmaceutical, Inc.1$25

Products named: VRAYLAR, COBENFY, ARISTADA, UZEDY, INGREZZA, CAPLYTA, SUBLOCADE, AUSTEDO XR.

Industry payments across MD — which companies pay providers there.